thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
Follow US
© thenewsfacts : All Rights Reserved.

Home » COVAXIN Commercialisation Rights In Mexico Given To Ocugen

COVID Vaccines

COVAXIN Commercialisation Rights In Mexico Given To Ocugen

TheNewsFacts
Last updated: April 18, 2022 8:21 pm
TheNewsFacts
Share
COVAXIN Commercialisation Rights In Mexico Given To Ocugen
SHARE

Covaxin Commercialisation rights has been secured by Ocugen Inc. Ocugen and Bharat Biotech has entered into amended agreement to expand the US firm’s Co-development, Supply and Commercialization, and the exclusive territory of commercialisation of Covaxin, a Covid-19 vaccine of the Indian vaccine maker, to Mexico.

COVAXIN™️ can be an ideal vaccination option for Mexico at this stage of the pandemic. As a whole virion, inactivated vaccine, it elicits robust cellular immune memory to SARS-CoV-2 and Variants of Concern. It offers logistical advantages that could support vaccine access in hard-to-reach communities.

COVAXIN commercialisation rights for all of North America

Furthermore, according to a press statement on April 18, Ocugen under the agreement will have COVAXIN™️ commercialization rights for all of North America.

The Mexican authorities have made conquering the COVID-19 pandemic a major priority, said Ocugen Inc co-founder and chief executive officer Dr Shankar Musunuri, adding that they met Mexico’s secretary of foreign affairs, Marcelo Ebrard, in Delhi.

“Covaxin is currently under review by COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) for emergency use among children between 2 and 18 years of age, and Ocugen is prepared to collaborate with the public health community to help their efforts,” said Dr Shankar Musunuri, viewing that Covaxin can be an ideal vaccination option for Mexico at this stage of the pandemic.

Bharat Biotech chairman and managing director Dr Krishna Ella said, “Covaxin is a safe and efficacious inactivated vaccine for all age groups as evident from its data from the global introduction.” Ella said the Indian vaccine innovator was fully supportive of team Ocugen in its endeavour to expedite technology transfer activities towards commercial-scale manufacturing of Covaxin in North America.

The license extension between Ocugen and Bharat Biotech with respect to commercialisation in Mexico includes the same profit share structure as in the United States, said the press statement.

TAGGED:Covaxincovaxin mexico rightsCovid vaccine covaxinocugen bharat biotech
Share This Article
Email Copy Link Print
Previous Article How to Get Social Media Followers as a Dog Owner? Tips and More How to Get Social Media Followers as a Dog Owner? Tips and More
Next Article Cristiano Ronaldo Shares His Greatest Pain, Strength in Life Today Cristiano Ronaldo Shares His Greatest Pain, Strength in Life Today

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
XFollow
InstagramFollow

Popular Posts

Mahashivratri 2024: Ujjain’s Hidden Gems Illuminated

Mahashivratri, the grand Hindu festival dedicated to Lord Shiva, is just around the corner. On…

By TheNewsFacts

Netflix New Squid Game: The Challenge to be the Biggest Reality Show

Netflix New Squid Game: The Challenge, a 10-episode new Reality series, will be the biggest…

By TheNewsFacts

Unfair Trade Practices : Indian Govt issues a strict warning to the Ed-Tech Industry

The Indian government has issued a warning to ed-tech businesses about, unfair trade practices. The…

By TheNewsFacts

You Might Also Like

India's Wait for COVAXIN WHO Approval to End Soon
COVID Vaccines

India’s Wait for COVAXIN WHO Approval to End Soon

By TheNewsFacts
India should announce COVID19 Vaccines for Children as they are the most vulnerable
COVID Vaccines

India should announce COVID19 Vaccines for Children as they are the most vulnerable

By TheNewsFacts
COVID Vaccine for 15-18 Years: Over 50% Children Gets COVAXIN
COVID Vaccines

COVID Vaccine for 15-18 Years: Over 50% Children Gets COVAXIN

By TheNewsFacts
Australia Now Welcomes COVAXIN-ated - It's Official
COVID Vaccines

Australia Now Welcomes COVAXIN-ated – It’s Official

By TheNewsFacts
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?